Delayed β1 Adrenergic Receptor Blockade Attenuates Cardiac Oxidative Stress, Remodeling, and Improves Cardiac Function in Post‐Myocardial Infarction
Weike Bao,Joanne Kuziw,Anna Zacco,Mike Ringenberg,Christine Schnackenberg
DOI: https://doi.org/10.1096/fasebj.30.1_supplement.725.1
2016-04-01
The FASEB Journal
Abstract:Our previous study showed that selective β1 adrenergic receptor blockade prevents cardiac oxidative stress and damage associated with acute myocardial ischemia/reperfusion (I/R) injury. A recent human study demonstrated that early intravenous β1 blockade before primary percutaneous coronary intervention reduced infarct size and increased left ventricular (LV) ejection fraction without adverse events. Another clinical study showed that β1 blocker treatment post‐hospitalization improved patient survival after acute myocardial infarction (MI). However, the mechanisms for the cardiac and survival benefits in post‐MI remain unclear. In the present study, we tested the hypothesis that delayed metoprolol treatment reduces cardiac maladaptive remodeling and improves cardiac function in a rat model of myocardial ischemia followed by a prolonged reperfusion, which mimics the contemporary clinical situations in which patients with heart attacks undergo revascularization. Male Sprague‐Dawley rats were subjected to a 30 min occlusion of the left anterior descending coronary artery followed by four weeks of reperfusion or sham surgery (n=6). In I/R rats, vehicle (n=12) or metoprolol (n=12, 100 mg/kg/day in drinking water) treatment commenced two days after I/R and continued until the end of the study. LV hemodynamics (pressure‐volume loop catheter), heart and LV weights (gravimetric measurements), cardiac histology (H&E and Masson's Trichrome stains), and cardiac oxidative stress (cardiac myosin binding protein C (cMyBPC) carbonylation) were determined at the end of the study. Compared to sham animals, I/R + vehicle significantly reduced stroke volume and ejection fraction by 40% and 21%, respectively, increased heart and LV weights by 19% and 16% (both p<0.01), respectively, increased cMyBPC carbonylation by 596%, resulted in fibroplasia and inflammatory cell infiltrates and mature collagen bundles in the lesion area, and infarcted the LV by 13%. After one week of I/R, metoprolol significantly reduced heart rate (EKG) by 11%, which confirmed the pharmacologically active dose. After four weeks of I/R, metoprolol significantly improved stroke volume and ejection fraction by 52% and 18%, respectively, significantly reduced heart and LV weights by 9% and 9%, respectively, significantly reduced cMyBPC carbonylation by 57%, trended towards less severe histological grades while it had no effect on infarct size. Our data indicate that in a rat model of MI, β1 adrenergic receptor blockade initiated after cardiac injury reduced oxidative stress and improved cardiac remodeling and function independent of infarct size.
cell biology,biochemistry & molecular biology,biology